Form 4: Teva Pharmaceutical Industries Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Vikki L. Conway, Acting Head of Global Human Resources at Teva Pharmaceutical Industries, sold shares to cover tax withholding obligations related to vesting restricted share units.
Summary
- On March 5, 2024, Vikki L. Conway, Acting Head of Global Human Resources at Teva Pharmaceutical Industries, executed transactions involving ordinary shares and restricted share units.
- Conway acquired 4,954 ordinary shares through the vesting of restricted share units.
- Simultaneously, Conway sold 1,427 ordinary shares at a weighted average price of $13.5154 per share to cover tax withholding obligations.
- The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 21, 2023.
- Following these transactions, Conway directly owns 15,219 ordinary shares and 4,957 restricted share units.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing reflects routine transactions related to executive compensation and tax obligations.
Positives
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, suggesting they were planned and not based on insider information.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for insights into management's perspective on the company's stock.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by some shareholders, although it is a common practice to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 2021/03/05 | Restricted share units were granted. |
| 2023/11/21 | Rule 10b5-1 trading plan adopted by the reporting person. |
| 2024/03/05 | Date of transactions: acquisition of shares via vesting of restricted share units and sale of shares to cover tax obligations. |
| 2024/03/05 | 4,954 restricted share units vested. |
| 2025/03/05 | 4,957 restricted share units vesting. |
| 2024/03/07 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.